As Egypt Constitution Passes, New Fights Lie Ahead


Tara Todras-Whitehill for The New York Times


Egyptian women walk into a polling station. Millions went to the polls to pass judgment on an Islamist-backed constitution, whose passage represented an important milestone in Egypt’s chaotic two-year transition to democracy. More Photos »







CAIRO — - Egyptians approved an Islamist-backed constitution, state news media said Sunday, and the headlines made clear that the political brawl around it set off has only begun.




“The People Sided With Democracy,” the flagship state newspaper Al Ahram declared.


“Wholesale violations,” ran the headline in the largest independent daily Al Masry Al Youm.


Passage of the constitution begins what its supporters call the first experiment in Islamist democracy and its results will be watched across the Arab world. Its approval is a victory for President Mohamed Morsi, of the Muslim Brotherhood’s political arm, who had sought to temporarily suspend the authority of the Egyptian courts in order to stop them from rulings he feared might block the referendum.


But a backlash against Mr. Morsi and his Islamist allies over their authoritarian tactics has now imposed new pressure to rebut charges that they intend to exploit loopholes in the charter to move Egypt toward theocracy.


In a press conference Sunday, opposition leaders called the charter illegitimate and vowed to use any peaceful means available to tear it down. “This is a constitution that lacks the most important prerequisite for a constitution: consensus,” Hamdeen Sabahi, a populist firebrand, declared. “This means we can’t build our future based on this text at all.”


But at the same time Mr. Sabahi and other political leaders said they planned to channel their movement against the charter into campaigns for the upcoming parliamentary elections, suggesting that at least for now to work with the process spelled out by the charter.


Amr Hamzawy, a political scientists and liberal political leader, said the size of the vote against the charter measured the opposition’s growing clout. “We have a majority than isn’t big and a minority that isn’t small. This means there is an evident division in society,” he said, adding, “We feel we’ve made a major achievement.”


About 64 percent of voters in the two-day referendum approved the new charter, Egyptian state media reported Sunday, citing preliminary local results. About 56.5 percent voted yes in last weekend’s first phase, which included Cairo, where a similar majority voted no. And in the more rural precincts that voted on Saturday more than 70 percent voted yes, mapping out Egypt’s cultural divide.


The turnout across both rounds remained low, at just over 30 percent of eligible voters, according to the preliminary figures. A referendum on a plan for the transition after the ouster of Hosni Mubarak drew about 41 percent of eligible voters.


The opposition leaders argued violations of voting procedures had compromised the results and demanded that election authorities rule on the allegations before issuing official results, expected Monday.


But the ballots were cast into transparent boxes and counted on the spot under the supervision of independent monitors, reducing opportunities for fraud. And the margin of the approval, by 4.5 million out of 16.2 million ballots, meant that rigging the results would have required systematic fraud.


International experts said that the constitution itself does not significantly alter the role of religion in Egyptian law. But it raised the stakes for future contests over who will interpret it.t Although the new charter preserves an article from the old constitution declaring the principles of Islamic law a main source of legislation, it adds a new arcticle, #219, broadly defining those principles in accord with established Sunni Muslim scholarship.


Zaid al-Ali (CQ), a researcher at the International Institute for Democracy and Electoral Assistance, an intergovernmental organization, said the constitution’s principle defects were not about religion. The biggest problem, he said, was that the charter protects the Egyptian military from legal and parliamentary oversight, engraving its autonomy in the constitution. Leaders of the Muslim Brotherhood had said privately for months that they were willing to provide the military such constitutional protections in order to ease the handover of power from the generals who assumed control from Mr. Mubarak.


A second problem, Mr. Ali said, was the failure to decentralize decision making. While most of the world has shifted power closer to the local level, he said, the Arab states have resisted out of a historic fear of fragmentation. “Because of the centralization in the Arab region, as soon as you step out of the capital you are in different universe,” Mr. Ali said. “It is an ineffectual way to meet people’s needs and services aren’t delivered.”


Meanwhile, a small group of President Morsi’s Islamist supporters on Sunday continued a sit-in outside the constitutional court, still determined to discourage it from any ruling that might interfere with the referendum before the results are official.


[[[Sectarian animosities continued to surround the vote. The Coptic Church pulled its representatives from the constitutional assembly in a dispute over the role of Islamic law in Egyptian jurisprudence, and before the vote many Christians said it was axiomatic that everyone of their faith would vote against the charter.


On Sunday, opposition leaders charged that in some precincts Islamists had intimidated Christians or blocked their access to the polls. But the allegations could not be confirmed.]]]


-v-


Read More..

'Hobbit' extends No. 1 journey with $36.7 million


LOS ANGELES (AP) — Tiny hobbit Bilbo Baggins is running circles around some of the biggest names in Hollywood.


Peter Jackson's "The Hobbit: An Unexpected Journey" took in $36.7 million to remain No. 1 at the box office for the second-straight weekend, easily beating a rush of top-name holiday newcomers.


Part one of Jackson's prelude to his "The Lord of the Rings" trilogy, the Warner Bros. release raised its domestic total to $149.9 million after 10 days. The film added $91 million overseas to bring its international total to $284 million and its worldwide haul to $434 million.


"The Hobbit" took a steep 57 percent drop from its domestic $84.6 million opening weekend, but business was soft in general as many people skipped movies in favor of last-minute Christmas preparations.


"The real winner this weekend might be holiday shopping," said Paul Dergarabedian, an analyst for box-office tracker Hollywood.com.


Tom Cruise's action thriller "Jack Reacher" debuted in second-place with a modest $15.6 million debut, according to studio estimates Sunday. Based on the Lee Child best-seller "One Shot," the Paramount Pictures release stars Cruise as a lone-wolf ex-military investigator tracking a sniper conspiracy.


Opening at No. 3 with $12 million was Judd Apatow's marital comedy "This Is 40," a Universal Pictures film featuring Paul Rudd and Leslie Mann reprising their roles from the director's 2007 hit "Knocked Up."


Paramount's road-trip romp "The Guilt Trip," featuring "Knocked Up" star Seth Rogen and Barbra Streisand, debuted weakly at No. 6 with $5.4 million over the weekend and $7.4 million since it opened Wednesday. Playing in narrower release, Paramount's acrobatic fantasy "Cirque du Soleil: Worlds Away" debuted at No. 11 with $2.1 million.


A 3-D version of Disney's 2001 animated blockbuster "Monsters, Inc." also had a modest start at No. 7 with $5 million over the weekend and $6.5 million since opening Wednesday.


Domestic business was off for the first time in nearly two months. Overall revenues totaled $112 million, down 12.6 percent from the same weekend last year, when Cruise's "Mission: Impossible — Ghost Protocol" debuted with $29.6 million, according to Hollywood.com.


Cruise's "Jack Reacher" opened at barely half the level as "Ghost Protocol," but with a $60 million budget, the new flick cost about $100 million less to make.


Starting on Christmas, Hollywood expects a big week of movie-going with schools out through New Year's Day and many adults taking time off. So Paramount and other studios are counting on strong business for films that started slowly this weekend.


"'Jack Reacher' will end up in a very good place. The movie will be profitable for Paramount," said Don Harris, the studio's head of distribution. "The first time I saw the movie I saw dollar signs. It certainly wasn't intended to be compared to a 'Mission: Impossible,' though."


Likewise, Warner Bros. is looking for steady crowds for "The Hobbit" over the next week, despite the debut of two huge newcomers — the musical "Les Miserables" and the action movie "Django Unchained" — on Christmas Day.


"We haven't reached the key holiday play time yet," said Dan Fellman, head of distribution for Warner. "It explodes on Tuesday and goes right through the end of the year."


In limited release, Kathryn Bigelow's Osama bin Laden manhunt saga "Zero Dark Thirty" played to packed houses with $410,000 in just five theaters, averaging a huge $82,000 a cinema.


That compares to a $4,654 average in 3,352 theaters for "Jack Reacher" and a $4,130 average in 2,913 cinemas for "This Is 40." ''The Guilt Trip" averaged $2,217 in 2,431 locations, and "Monsters, Inc." averaged $1,925 in 2,618 cinemas. Playing just one matinee and one evening show a day at 840 theaters, "Cirque du Soleil" averaged $2,542.


Since opening Wednesday, "Zero Dark Thirty" has taken in $639,000. Distributor Sony plans to expand the acclaimed film to nationwide release Jan. 11, amid film honors and nominations leading up to the Feb. 24 Academy Awards.


Opening in 15 theaters from Lionsgate banner Summit Entertainment, Naomi Watts and Ewan McGregor's tsunami-survival drama "The Impossible" took in $138,750 for an average of $9,250.


A fourth new release from Paramount, "The Sopranos" creator David Chase's 1960s rock 'n' roll tale "Not Fade Away," debuted with $19,000 in three theaters, averaging $6,333.


Estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Hollywood.com. Where available, latest international numbers are also included. Final domestic figures will be released Monday.


1. "The Hobbit: An Unexpected Journey," $36.7 million ($91 million international).


2. "Jack Reacher," $15.6 million ($2.5 million international).


3. "This Is 40," $12 million.


4. "Rise of the Guardians," $5.9 million ($13.7 million international).


5. "Lincoln," $5.6 million.


6. "The Guilt Trip," $5.4 million.


7. "Monsters, Inc." in 3-D, $5 million.


8. "Skyfall," $4.7 million ($9 million international),


9. "Life of Pi," $3.8 million ($23.2 million international).


10. "The Twilight Saga: Breaking Dawn — Part 2," $2.6 million.


___


Online:


http://www.hollywood.com


http://www.rentrak.com


___


Universal and Focus are owned by NBC Universal, a unit of Comcast Corp.; Sony, Columbia, Sony Screen Gems and Sony Pictures Classics are units of Sony Corp.; Paramount is owned by Viacom Inc.; Disney, Pixar and Marvel are owned by The Walt Disney Co.; Miramax is owned by Filmyard Holdings LLC; 20th Century Fox and Fox Searchlight are owned by News Corp.; Warner Bros. and New Line are units of Time Warner Inc.; MGM is owned by a group of former creditors including Highland Capital, Anchorage Advisors and Carl Icahn; Lionsgate is owned by Lions Gate Entertainment Corp.; IFC is owned by AMC Networks Inc.; Rogue is owned by Relativity Media LLC.


Read More..

Genetic Gamble : Drugs Aim to Make Several Types of Cancer Self-Destruct


C.J. Gunther for The New York Times


Dr. Donald Bergstrom is a cancer specialist at Sanofi, one of three companies working on a drug to restore a tendency of damaged cells to self-destruct.







For the first time ever, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers independently of where they originated — breast, prostate, liver, lung. The drugs go after an aberration involving a cancer gene fundamental to tumor growth. Many scientists see this as the beginning of a new genetic age in cancer research.




Great uncertainties remain, but such drugs could mean new treatments for rare, neglected cancers, as well as common ones. Merck, Roche and Sanofi are racing to develop their own versions of a drug they hope will restore a mechanism that normally makes badly damaged cells self-destruct and could potentially be used against half of all cancers.


No pharmaceutical company has ever conducted a major clinical trial of a drug in patients who have many different kinds of cancer, researchers and federal regulators say. “This is a taste of the future in cancer drug development,” said Dr. Otis Webb Brawley, the chief medical and scientific officer of the American Cancer Society. “I expect the organ from which the cancer came from will be less important in the future and the molecular target more important,” he added.


And this has major implications for cancer philanthropy, experts say. Advocacy groups should shift from fund-raising for particular cancers to pushing for research aimed at many kinds of cancer at once, Dr. Brawley said. John Walter, the chief executive officer of the Leukemia and Lymphoma Society, concurred, saying that by pooling forces “our strength can be leveraged.”


At the heart of this search for new cancer drugs are patients like Joe Bellino, who was a post office clerk until his cancer made him too sick to work. Seven years ago, he went into the hospital for hernia surgery, only to learn he had liposarcoma, a rare cancer of fat cells. A large tumor was wrapped around a cord that connects the testicle to the abdomen. “I was shocked,” he said in an interview this summer.


Companies have long ignored liposarcoma, seeing no market for drugs to treat a cancer that strikes so few. But it is ideal for testing Sanofi’s drug because the tumors nearly always have the exact genetic problem the drug was meant to attack — a fusion of two large proteins. If the drug works, it should bring these raging cancers to a halt. Then Sanofi would test the drug on a broad range of cancers with a similar genetic alteration. But if the drug fails against liposarcoma, Sanofi will reluctantly admit defeat.


“For us, this is a go/no-go situation,” said Laurent Debussche, a Sanofi scientist who leads the company’s research on the drug.


The genetic alteration the drug targets has tantalized researchers for decades. Normal healthy cells have a mechanism that tells them to die if their DNA is too badly damaged to repair. Cancer cells have grotesquely damaged DNA, so ordinarily they would self-destruct. A protein known as p53 that Dr. Gary Gilliland of Merck calls the cell’s angel of death normally sets things in motion. But cancer cells disable p53, either directly, with a mutation, or indirectly, by attaching the p53 protein to another cellular protein that blocks it. The dream of cancer researchers has long been to reanimate p53 in cancer cells so they will die on their own.


The p53 story began in earnest about 20 years ago. Excitement ran so high that, in 1993, Science magazine anointed it Molecule of the Year and put it on the cover. An editorial held out the possibility of “a cure of a terrible killer in the not too distant future.”


Companies began chasing a drug to restore p53 in cells where it was disabled by mutations. But while scientists know how to block genes, they have not figured out how to add or restore them. Researchers tried gene therapy, adding good copies of the p53 gene to cancer cells. That did not work.


Then, instead of going after mutated p53 genes, they went after half of cancers that used the alternative route to disable p53, blocking it by attaching it to a protein known as MDM2. When the two proteins stick together, the p53 protein no longer functions. Maybe, researchers thought, they could find a molecule to wedge itself between the two proteins and pry them apart.


The problem was that both proteins are huge and cling tightly to each other. Drug molecules are typically tiny. How could they find one that could separate these two bruisers, like a referee at a boxing match?


In 1996, researchers at Roche noticed a small pocket between the behemoths where a tiny molecule might slip in and pry them apart. It took six years, but Roche found such a molecule and named it Nutlin because the lab was in Nutley, N.J.


But Nutlins did not work as drugs because they were not absorbed into the body.


Roche, Merck and Sanofi persevered, testing thousands of molecules.


At Sanofi, the stubborn scientist leading the way, Dr. Debussche, maintained an obsession with p53 for two decades. Finally, in 2009, his team, together with Shaomeng Wang at the University of Michigan and a biotech company, Ascenta Therapeutics, found a promising compound.


The company tested the drug by pumping it each day into the stomachs of mice with sarcoma.


Read More..

Nicolás Maduro, Chávez’s Chosen Successor, Draws Mixed Opinions





CARACAS, Venezuela — Nicolás Maduro, the handpicked successor of Venezuela’s ailing president, Hugo Chávez, stood on a stage this month and gave a barnburner of a speech in classic Chávez style. He shouted until his voice gave out, swore an oath of loyalty to the revolution and blasted its opponents. But when the crowd started to chant his name, he quickly cut them off, shouting into the microphone: “Chávez! Chávez! Chávez!”




One thing Mr. Maduro has certainly learned in his years at Mr. Chávez’s side: do not outshine the boss.


That remains true even with Mr. Chávez, 58, in delicate health in Cuba after surgery for cancer, and even after Mr. Chávez told the nation that if illness prevents him from governing, Mr. Maduro, 50, currently the vice president, should lead in his place.


“He’s known as a yes man, and he’s somebody that has never shown an independent streak,” said David Smilde, a senior fellow of the Washington Office on Latin America, a research organization. “That’s what has been key for him, always put the light on Chávez.”


But for all Mr. Maduro’s faithfulness, some see signs that he may be a different sort of leader, someone more moderate and willing to negotiate than the combative Mr. Chávez. Not only could that open up the possibility of dialogue with the political opposition inside the country, but it could also mean a softening of Venezuela’s strident foreign policy and its antagonistic relationship with the United States.


“He is a moderate man, a pragmatic man,” said María Emma Mejía, a former Colombian foreign minister who worked closely with Mr. Maduro when she was secretary general of Unasur, an organization of South American nations. She credited him with helping to improve Venezuela’s relations with Colombia after years of tension. “He is not dogmatic in a way that rejects other people’s positions,” she added.


Still, others say that he has adhered to Mr. Chávez’s policies so closely for so long that it is hard to know what his own choices would be — if he even has the latitude to make them.


A former bus driver and transit union leader, Mr. Maduro has been a supporter of Mr. Chávez at least since the aftermath of Mr. Chávez’s failed 1992 coup. He became a legislator when Mr. Chávez became president in 1999, then helped write a new Constitution, and by 2005 he had become the head of the National Assembly. He was made foreign minister in 2006 and continues in that post today.


He often travels with Mr. Chávez, and in the last year and a half, as Mr. Chávez has spent weeks in Cuba receiving treatment for cancer, Mr. Maduro was often there with him. After Mr. Chávez was elected to a new six-year term in October, he made Mr. Maduro his vice president.


That is a record of unusual constancy in a government with a merry-go-round of ministers who come and go at Mr. Chávez’s whim, often shunted aside for displeasing their boss or for showing a taste for the spotlight.


“He was able to be in the government, never threaten Chávez, never be marginalized, and it will be interesting to see what happens when he actually has to have an independent voice,” Mr. Smilde said.


A former South American diplomat who met often with Mr. Maduro in recent years said that more than most foreign ministers, Mr. Maduro seemed held back by his president’s micromanagement.


“I always saw him as being glued to Chávez,” the ex-diplomat said, speaking on the condition of anonymity because of the sensitive nature of the topic. “I always saw him as a messenger, and I never had a signal that would make me think he was a leader. But I think he’s learned a lot from Chávez, being so close.”


Now Mr. Maduro needs to win over the party faithful, who have a deep emotional connection with Mr. Chávez and often blame his lieutenants for the inefficiency and corruption that bedevil the government.


And while Mr. Chávez can give him his political blessing, he cannot give him his charisma. Mr. Maduro has been very much in the public eye since Mr. Chávez left for surgery in Cuba, often speaking before large crowds of loyalists. Early on, with emotions high over the president’s condition, his audience responded. But last week, as Mr. Maduro spoke at oath-taking ceremonies for newly elected governors, his speeches were often greeted with polite applause rather than full-throated devotion.


“I don’t see Maduro as a presidential candidate,” said Carlos Bolívar, 40, a street vendor in Caracas who supports Mr. Chávez. “He doesn’t have the skill. He’s too sealed up.”


But, he added, “If that’s what the president says, we have to accept it.”


Mr. Maduro grew up in Caracas in what a friend said was a family of modest means. His father was involved in left-wing politics and the labor movement. As a youth, Mr. Maduro became active in left-wing politics, too.


After high school he went to Cuba for political training, then returned and eventually went to work as a bus driver.


Fairly or not, that job has often defined him. Mr. Maduro’s critics sometimes dismiss him as unqualified to hold higher office. Mr. Chávez mocked that perception in October when he announced Mr. Maduro’s appointment as vice president, saying, “Look where Nicolás has gotten to, the bus driver,” he said. “How they have made fun of him.”


Read More..

Analysis: Apple’s swoon exposes risk lurking in mutual funds






NEW YORK (Reuters) – The nearly 28 percent decline in shares of Apple Inc since mid-September isn’t just painful to individual shareholders. It’s also being felt by investors who chased hot mutual funds that loaded up on Apple as the stock raced to a record $ 705 per share.


Apple makes up 10 percent or more of assets in 117 out of the 1,119 funds that own its shares, according to data from Lipper, a Thomson Reuters company. Those big stakes have contributed positively to each fund’s annual performance to date, with Apple still up about 32 percent for the year. It was trading at $ 527.73 soon after the opening on Friday.






But that year-to-date outcome may not accurately reflect the performance of the funds for individual investors. All told, approximately $ 4.5 billion has been added to funds with overweight stakes in Apple this year, according to Morningstar data. The majority of these dollars were invested after March and after Apple first exceeded $ 600 per share – meaning many investors have been riding down with the decline.


The $ 302 million Matthew 25 fund, for instance, holds 17.4 percent of its assets in Apple, according to Lipper. The fund’s 31.9 percent gain through Thursday makes it one of the top performing funds for the year.


Most of its Apple shares were bought years ago at a bargain basement price of about $ 125 per share. But $ 158.9 million of the fund’s assets – or 53 percent – were invested after the end of March, when Apple was trading near $ 615 per share, according to Morningstar data.


For those investors that bought after March, all that concentration in Apple hasn’t led to a stellar gain but rather a drag on the portfolio. Someone who invested in Matthew 25 in early April has seen the value of the fund’s Apple stake fall about 19 percent, while someone who invested at the beginning of September has watched that outsized Apple stake drop 27.2 percent.


In turn, the majority of the fund’s investors have reaped a much more modest performance than its year-end numbers suggest. Since the end of March, the fund has gained 6.7 percent, according to Morningstar data, far less than its 31 percent year-to-date gain and about two percentage points more than the benchmark Standard & Poor’s 500 index.


Since, September the fund is down nearly 3 percent through Thursday’s close, compared with a 1.1 percent decline in the S&P 500 in that period.


The impact of Apple’s falling stock price shows some of the drawbacks of portfolio concentration, experts say. These stakes can leave the funds overexposed to the ups and downs of one company – counter to what most mutual funds are supposed to do for investors.


“Any time you get over 10 percent of the portfolio in one company it’s a red flag,” said Michel Herbst, director of active fund research at Morningstar. Many fund managers do have risk management rules that prevent them from devoting more than 5 percent to 6 percent of their portfolio to any one stock, he said.


Then again, some funds purposely invest in just a few stocks. Mark Mulholland, the portfolio manager of the Matthew 25 fund, said that taking concentrated positions in companies is the only way to beat an index over longer periods of time.


‘RIGHT-SIZING’ PORTFOLIOS


Along with concerns about iPhone sales in China and tax-motivated selling among people who want to avoid potentially higher capital gains taxes in 2013, the wide fund ownership of Apple may be a factor in the size of the stock’s recent declines, fund managers said. In addition, with so many funds already heavily invested in the high-priced stock, there may be fewer marginal buyers available to push prices up again when shares begin to dip.


“The stock didn’t go from $ 700 to $ 520 because people didn’t like the new iPad. It’s become a favorite short of hedge funds because they know they can get in on this,” said Mark Spellman, a portfolio manager of the $ 300 million Value Line Income and Growth fund with a small position in Apple.


Short interest in the stock rose to 20.6 million shares at the end of November from 15.1 million shares at the end of September, according to Nasdaq.


“Some of my competitors have 12 percent of their assets in Apple, which I think is ludicrous”, said Spellman, who said the company is no longer trading on its fundamentals.


Sandy Villere, who has a 2.5 percent weighting of Apple in his $ 276 million Villere Balanced fund, said that some mutual fund managers are selling shares because of the over-weighting.


“Right now many people who did take huge overweight positions are right-sizing their portfolios to get it in line with their regular weightings,” he said.


Still, some bullish investors see the stock’s recent declines as a buying opportunity.


Mulholland, the Matthew 25 portfolio manager, continues to say that shares should be priced at over $ 1,000 per share based on his valuation of the company at 10 times enterprise value divided by earnings before interest, taxes, depreciation and amortization (EBITDA). Apple trades at about 7 times that figure now.


Wall Street analysts’ average price target as of Thursday is $ 742.56, according to Thomson Reuters data. But Mulholland is happy to be more bullish than his peers.


“I’m glad that I’m able to get it at these prices,” he said.


(Reporting By David Randall; Editing by Jennifer Merritt)


Tech News Headlines – Yahoo! News





Title Post: Analysis: Apple’s swoon exposes risk lurking in mutual funds
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Ashton Kutcher files for divorce from Demi Moore


LOS ANGELES (AP) — Ashton Kutcher filed court papers Friday to end his seven-year marriage to actress Demi Moore.


The actor's divorce petition cites irreconcilable differences and does not list a date that the couple separated. Moore announced last year that she was ending her marriage to the actor 15 years her junior, but she never filed a petition.


Kutcher's filing does not indicate that the couple has a prenuptial agreement. The filing states Kutcher signed the document Friday, hours before it was filed in Los Angeles Superior Court.


Kutcher and Moore married in September 2005 and until recently kept their relationship very public, communicating with each other and fans on the social networking site Twitter. After their breakup, Moore changed her name on the site from (at)mrskutcher to (at)justdemi.


Kutcher currently stars on CBS' "Two and a Half Men."


Messages sent to Kutcher's and Moore's publicists were not immediately returned Friday.


Moore, 50, and Kutcher, 34, created the DNA Foundation, also known as the Demi and Ashton Foundation, in 2010 to combat the organized sexual exploitation of girls around the globe. They later lent their support to the United Nations' efforts to fight human trafficking, a scourge the international organization estimates affects about 2.5 million people worldwide.


Moore was previously married to actor Bruce Willis for 13 years. They had three daughters together — Rumer, Scout and Tallulah Belle — before divorcing in 2000. Willis later married model-actress Emma Heming in an intimate 2009 ceremony at his home in Parrot Cay in the Turks and Caicos Islands that attended by their children, as well as Moore and Kutcher.


Kutcher has been dating former "That '70s Show" co-star Mila Kunis.


The divorce filing was first reported Friday by People magazine.


___


Anthony McCartney can be reached at http://twitter.com/mccartneyAP.


Read More..

The Neediest Cases: The Daughter of a Sick Woman Falls Prey to a Craigslist Scam





Sitting side by side on their living room sofa, Patricia Morales and her daughter, Katherine, could be any mother-daughter duo. Both have dark hair, dark eyes and welcoming, infectious smiles.







Librado Romero/The New York Times

Patricia Morales, 62, at home in the Bronx. Her treatment for ailments like rheumatoid arthritis and hepatitis C led to depression.






2012-13 Campaign


Previously recorded:

$3,375,394



Recorded Wednesday:

182,251



*Total:

$3,557,645



Last year to date:

$3,320,812




*Includes $709,856 contributed to the Hurricane Sandy relief efforts.

The Neediest CasesFor the past 100 years, The New York Times Neediest Cases Fund has provided direct assistance to children, families and the elderly in New York. To celebrate the 101st campaign, an article will appear daily through Jan. 25. Each profile will illustrate the difference that even a modest amount of money can make in easing the struggles of the poor.


Last year donors contributed $7,003,854, which was distributed to those in need through seven New York charities.







The Youngest Donors


If your child or family is using creative techniques to raise money for this year’s campaign, we want to hear from you. Drop us a line on Facebook or talk to us on Twitter.





But the ties that bind them go beyond their genes, beyond the bodies they were born with.


“It’s called a neck ring. It’s a silver curved barbell, one inch,” Katherine, 20, said as she swept aside her shoulder-length black hair to show the piercing in the back of her neck, a show of solidarity with her mother. She had it done when she was 16. “I wanted to know what it felt like for my mom.”


Her mother then turned around and outlined with her finger two lengthy scars that run down her back.


“I’ve had a lot of physical problems,” Ms. Morales, 62, said. Shaking her head at her daughter’s piercing, she added, “I’ve had rods put in my upper and lower spine, but I could never do that.”


The rods were surgically planted to treat herniated discs, the result of having a cruel combination of osteoporosis, hepatitis C, fibromyalgia and rheumatoid arthritis. Ms. Morales contracted hepatitis C from a blood transfusion she received in 1972 after the birth of her only son, she said.


“I didn’t even know about it until 10 years ago,” she said. “My liver blood count was a little high.”


Since the diagnosis, Ms. Morales, a former schoolteacher, has ridden the arduous highs and lows common to patients with hepatitis C. Her treatments for the disease, which debilitates the liver over time, have included pills and injections that can cause depression. Ms. Morales, a single parent, found an unforgiving salve in alcohol.


“I was depressed; I was totally drunk,” she said. “I didn’t want to live anymore.”


Then, about a year ago, she reached a turning point when visiting her hepatitis C specialist.


“I was 210 pounds,” she said. “The doctor said: ‘You have to stop drinking. You have to lose weight.’ ”


To help combat the depression, her doctor referred her to Jewish Association Serving the Aging, a beneficiary agency of UJA-Federation of New York, one of the organizations supported by The New York Times Neediest Cases Fund. She began weekly counseling sessions with a social worker and started taking an antidepressant medication. The federation drew about $600 from the fund in May so that Ms. Morales could buy a mattress.


“I had a horrible bed,” she said. “I felt like I was sleeping on rocks, and with rods in my back, I was waking up every hour.”


After several months of therapy and starting a diet, Ms. Morales was on her way to losing 60 pounds. Today, she weighs 148.


Light was starting to show itself again when the family took an unexpected financial hit this summer. While taking time off from attending Hostos Community College, Katherine Morales looked for work on Craigslist.


“I saw my mom, and I realized I needed to get a job,” Katherine said shyly. “This guy asked me to be his personal assistant, and he asked me to wire money.”


Offering $400 a week, the man requested help transferring almost $2,000 from what he said was his wife’s account. He transferred the money to Katherine’s account, asking her to wire it to a bank account in Malaysia.


Shortly after she wired the money, the bank froze the account, which Katherine and her mother shared. It was then that Katherine realized she had been the victim of a scam. The money transferred into her account turned out to have been stolen, and she was responsible for repaying it.


Katherine went to detectives immediately with more than 20 pages of evidentiary e-mails, but found that she was unable to file a complaint.


“They told me it wasn’t enough,” she said. “These things happen all the time.”


They lost almost $2,000.


Ms. Morales lives on a fixed income. She receives just over $700 a month from Social Security and $200 month in food stamps. The rent for the apartment she shares with her daughter in the Throgs Neck neighborhood of the Bronx is $230, and Ms. Morales has a monthly combined phone and cable bill of $140. Ms. Morales has a son, but he is unable to help the family.


Falling behind on her bills, Ms. Morales turned once again to JASA for help paying a combined phone and cable bill of nearly $200, a grant the agency drew from the Neediest Cases Fund.


“It was terrible, because my intention was to help my mom,” said Katherine, who has since found a part-time job at a vitamin shop.


Ms. Morales has been feeling much better, but she is nervous about an appointment with her hepatitis C specialist in January.


“I’m taking things one day at a time, but I’m looking forward to someone taking care of me,” she said. “I want to live a little bit longer, but not that long.”


“Why are you putting a time limit on it?” Katherine said, jokingly. “Seventy’s the new 20!” she added, nudging her mother in the side. “Remember, the doctor said you wouldn’t live past your late 50s, but you did.”


Read More..

Departure by Kerry Creates Senate Opportunities in Massachusetts





President Obama’s decision to pluck John Kerry of Massachusetts from the Senate to be his new secretary of state sets the stage for a comeback by departing Senator Scott P. Brown, a Republican, even before he leaves office early next month.




It also may give Victoria Reggie Kennedy the chance for at least temporary membership in the club where her late husband, Senator Edward M. Kennedy, served for almost half a century. It could even give Edward Kennedy Jr., the senator’s son, a chance to follow in his father’s footsteps, if rumors of his interest in serving full time prove true.


And it almost certainly sets off a political brawl among a half-dozen Democrats, many of them current members of the House, for the chance to become one of only 100 senators in Washington and to serve in the majority, as opposed to remaining one of 435 House members and languishing in the minority.


Gov. Deval Patrick is expected to announce very soon a date for a special election to replace Mr. Kerry as well as a pick for a caretaker to serve for a few months until the winner of the special election is sworn in.


Mr. Patrick has been contacted by several people. He met a few weeks ago with Mrs. Kennedy, according to a Democrat with knowledge of the meeting. Mrs. Kennedy was not interested in running for a full term for Senate, this person said, but was “very open to the idea” of serving as a placeholder.


Mr. Patrick also spoke with Michael Dukakis, the former governor and presidential candidate, but he had no interest in either being a caretaker or running for a full term.


If the Democrats cannot agree on a consensus candidate to run in the special election, the aspirants will face off in a primary, which would be held about six weeks before the special election. It could be an unpleasant affair for campaign-weary voters and a boon for local television stations, which would reap the financial rewards of an advertising barrage.


The Republicans would face a primary, too, except that Mr. Brown, who lost his seat last month to Elizabeth Warren, is already the consensus candidate if he wants to run. Besides, there are not many other Republicans in deep blue Massachusetts who are considered plausible contenders, with the exception of William F. Weld, the former governor, who has said he would defer to Mr. Brown.


It has been a foregone conclusion in Massachusetts for some time that Mr. Obama would name Mr. Kerry to replace Hillary Rodham Clinton, who long ago said she would serve only one term as secretary of state.


It has been an equally foregone conclusion that Mr. Brown would run for Mr. Kerry’s seat if it opened up, prompting various polling organizations to start testing Mr. Brown’s strength against possible opponents. In a poll released Thursday, WBUR, the Boston NPR affiliate, found him leading some of the likely Democratic candidates by at least 17 percentage points. It did not test him against Edward Kennedy Jr.


But Mr. Brown has not said explicitly whether he would run; he is expected to make an announcement soon. If he decides to compete, it would be his third statewide race in three years. Some supporters have suggested he might be better off running for governor in 2014, in part because Massachusetts voters seem more comfortable with Republicans if they are not beholden to an ideological agenda in Washington.


Another consideration is that after the last election, some Republican money may have dried up.


“The Republican money guys are dead tired and don’t want another race,” said Rob Gray, a Republican strategist. Donors were drained, he said, by the $78-million Brown-Warren race, the most expensive in the country, and by Mitt Romney’s presidential campaign, neither of which yielded much return on the investment.


On the Democratic side, the three most prominent names mentioned are all members of the House and all from Boston or the greater metro area: Edward J. Markey, first elected in 1976; Michael Capuano, elected in 1998; and Stephen Lynch, elected in a special election in 2001. Martin Meehan, a former Congressman and now chancellor of the University of Massachusetts at Lowell, has said he would not run. Mr. Brown beat them all in the WBUR poll, which may be a function at this point of his high name-recognition.


In addition to Mr. Kennedy, other possibilities include the United States attorney, Carmen Ortiz, and Martha Coakley, the state attorney general who lost badly to Mr. Brown in the 2010 special election but who has rebounded and become one of the most popular politicians in the state.


A special election for the Kerry seat would likely occur in May or June. State law says it must take place between 145 and 160 days after a vacancy occurs. A vacancy is deemed to occur once the departing senator files a letter of resignation, even if the resignation is not effective until a later date.


It is not clear if Mr. Kerry will submit such a letter right away or if he will wait until he is confirmed by the Senate. Even Republicans have said that Mr. Kerry would sail through the confirmation process.


Mr. Patrick has indicated that he wanted to appoint an interim senator, as he did after Senator Kennedy’s death in 2009, rather than someone who wants to run for a full six-year term in 2014 when Mr. Kerry’s term expires.


“I expect to do the same thing I did last time,” Mr. Patrick told reporters recently. “I’m not ruling out other options. But, as a practical matter, it’s hard for me to imagine how you could serve in the Senate for a four-month period and also run a statewide campaign in a four-month period and do both of them well.”


Mr. Patrick has ruled out appointing himself but has said he would not run for a third term, setting up an open race for governor in 2014.


Read More..

Nokia, RIM settle old disputes in new patent pact






HELSINKI (AP) — Nokia Corp. and Canadian smartphone rival Research In Motion have agreed on a new patent licensing pact which will end all existing litigation between the two struggling companies, the Finnish firm said Friday.


The agreement includes a “one-time payment and on-going payments, all from RIM to Nokia,” Nokia said, but did not disclose “confidential” terms.






Last month, Nokia sued the Blackberry maker for breach of contract in Britain, the United States and Canada over cellular patents they agreed in 2003. RIM claimed the license — which covered patents on “standards-essential” technologies for mobile devices— should also have covered patents for non-essential parts, but the Arbitration Institute of Stockholm Chamber of Commerce ruled against RIM’s claims.


Major manufacturers of phones and wireless equipment are increasingly turning to patent litigation as they jockey for an edge to expand their share of the rapidly growing smartphone market.


Nokia is among leading patent holders in the wireless industry. It has already received a $ 565 million royalty payment from Apple Inc. to settle long-standing patent disputes and filed claims in the United States and Germany alleging that products from HTC Corp. and Viewsonic Corp. infringe a number of its patents.


The company says it has invested €45 billion ($ 60 billion) during the last 20 years in research and development and has one of the wireless industry’s largest IPR portfolios claiming some 10,000 patent families.


Nokia’s share price closed down 3.5 percent at €3.05 on the Helsinki Stock Exchange.


Wireless News Headlines – Yahoo! News





Title Post: Nokia, RIM settle old disputes in new patent pact
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

PSY's 'Gangnam Style' reaches 1B views on YouTube


NEW YORK (AP) — Viral star PSY has reached a new milestone on YouTube.


The South Korean rapper's video for "Gangnam Style" has reached 1 billion views, according to YouTube's own counter. It's the first time any clip has surpassed that mark on the streaming service owned by Google Inc.


It shows the enduring popularity of the self-deprecating video that features Park Jae-sang's giddy up-style dance moves. The video has been available on YouTube since July 15, averaging more than 200 million views per month.


Justin Bieber's video for "Baby" held the previous YouTube record at more than 800 million views.


PSY wasn't just popular on YouTube, either. Earlier this month Google announced "Gangnam Style" was the second highest trending search of 2012 behind Whitney Houston, who passed away in February.


Read More..